Cross-source identity
National Provider Identifier 1336324060 as it appears in every federal dataset Fonteum holds. Each row is a distinct public source; the chip carries the source and the snapshot date behind that field — the record-level form of the source-provenanced graph.
| Federal source | Key | What it provides | Provenance |
|---|
| CMS NPPES | NPI 1336324060 | Registry identity — dermatologist, taxonomy 207N00000X | Source:CMS NPPESSnapshot 2026-05-06 |
| CMS Open Payments | NPI 1336324060 | 137 industry-payment records, 2024 | Source:CMS Open PaymentsSnapshot PY2024 |
| CMS Medicare Part D | NPI 1336324060 | 16 drugs prescribed, 2024 | Source:CMS Part DSnapshot DY2024 |
| Fonteum entity graph | entity 7cee4a16… | Canonical resolved node · 2 identifier(s) · 2 edge(s) | Source:Entity graphSnapshot 2026-06-11 |
Industry payments
Payments and transfers of value this clinician received from drug and device manufacturers, disclosed under the Physician Payments Sunshine Act. A payment is a disclosure, not a judgment.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $118,788 | 28 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31,570 | 9 |
| Travel and Lodging | $27,234 | 26 |
| Honoraria | $16,989 | 4 |
| Food and Beverage |
| Manufacturer | Amount | Records |
|---|---|---|
| Lilly Usa, Llc | $82,689 | 20 |
| Pfizer Inc. | $58,002 | 36 |
| Abbvie Inc. | $28,562 |
Prescribing
Prescriptions written under Medicare Part D, aggregated by drug across the program. Totals reflect claims paid, not patients treated.
| Drug | Claims | Drug cost |
|---|---|---|
| Dupixent Syringe(Dupilumab) | 41 | $140,402 |
| Rinvoq(Upadacitinib) | 11 | $69,880 |
| Olumiant(Baricitinib) | 11 | $59,470 |
| Siliq(Brodalumab) | 11 | $50,783 |
| Minoxidil | 228 | $5,154 |
Beneficiary counts below 11 are suppressed by CMS — the total shown is a lower bound.
Quality
CMS Quality Payment Program Merit-based Incentive Payment System (MIPS) final score, where this clinician participated. Absence of a score is not a quality signal — many clinicians report through a group or are exempt.
Enrollment & sanctions
Screening aid — re-confirm any match against the issuing list before acting. A clean result means no record was found in the federal OIG LEIE or the state Medicaid lists Fonteum currently holds (NY, OH, GA), not a guarantee that none exists elsewhere. Not a legal or credentialing certification.
Ownership & affiliations
One-hop relationships in the resolved entity graph — chain membership, ownership, and operation edges, each backed by a federal source row. Most individual clinicians carry none; edges populate for owners and organizations as the Lane D backfill runs.
| Relationship | Entity | Source |
|---|---|---|
| ← pays | E.R. Squibb & Sons, L.L.C. (NJ) | cms_open_payments |
| ← pays | Abbvie Inc. (IL) | cms_open_payments |
| 44 |
| 29 |
| Eli Lilly And Company | $26,251 | 18 |
| E.R. Squibb & Sons, L.L.C. | $20,415 | 3 |